After Covishield maker AstraZeneca initiated the worldwide withdrawal of its COVID-19 vaccine, manufacturer Serum Institute of India said, "From the outset, we've disclosed all rare...side-effects, including Thrombosis with Thrombocytopenia Syndrome, in the packaging insert in 2021." "We fully understand the ongoing concerns and it's crucial to emphasise our commitment to transparency," it added.